Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Biogen Inc. stock logo
BIIB
Biogen
$222.75
+1.4%
$211.93
$189.44
$319.76
$32.43B-0.011.20 million shs754,499 shs
Netflix, Inc. stock logo
NFLX
Netflix
$612.09
+0.4%
$603.11
$329.51
$639.00
$263.79B1.234.38 million shs2.06 million shs
NIKE, Inc. stock logo
NKE
NIKE
$93.39
-0.2%
$95.07
$88.66
$126.46
$140.96B1.079.15 million shs6.43 million shs
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Biogen Inc. stock logo
BIIB
Biogen
+1.38%+4.33%+7.86%-7.56%-28.89%
Netflix, Inc. stock logo
NFLX
Netflix
+0.43%+8.31%-0.99%+9.04%+82.48%
NIKE, Inc. stock logo
NKE
NIKE
-0.21%+1.06%+2.63%-10.63%-24.39%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Biogen Inc. stock logo
BIIB
Biogen
4.9868 of 5 stars
4.35.00.03.53.33.32.5
Netflix, Inc. stock logo
NFLX
Netflix
4.461 of 5 stars
2.35.00.02.82.92.52.5
NIKE, Inc. stock logo
NKE
NIKE
4.5656 of 5 stars
3.33.04.21.52.42.51.3

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Biogen Inc. stock logo
BIIB
Biogen
2.65
Moderate Buy$290.9230.60% Upside
Netflix, Inc. stock logo
NFLX
Netflix
2.60
Moderate Buy$631.153.11% Upside
NIKE, Inc. stock logo
NKE
NIKE
2.58
Moderate Buy$116.2624.49% Upside

Current Analyst Ratings

Latest BIIB, NKE, and NFLX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/3/2024
Biogen Inc. stock logo
BIIB
Biogen
HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$339.00 ➝ $342.00
5/2/2024
Netflix, Inc. stock logo
NFLX
Netflix
CICC Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$650.00
4/30/2024
NIKE, Inc. stock logo
NKE
NIKE
Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$115.00
4/29/2024
Biogen Inc. stock logo
BIIB
Biogen
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$270.00 ➝ $270.00
4/25/2024
Biogen Inc. stock logo
BIIB
Biogen
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$215.00 ➝ $200.00
4/25/2024
Biogen Inc. stock logo
BIIB
Biogen
Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$213.00 ➝ $215.00
4/25/2024
Biogen Inc. stock logo
BIIB
Biogen
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$325.00 ➝ $300.00
4/24/2024
Biogen Inc. stock logo
BIIB
Biogen
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$294.00
4/19/2024
Biogen Inc. stock logo
BIIB
Biogen
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$290.00 ➝ $270.00
4/19/2024
Netflix, Inc. stock logo
NFLX
Netflix
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$650.00 ➝ $700.00
4/19/2024
Netflix, Inc. stock logo
NFLX
Netflix
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$640.00 ➝ $650.00
(Data available from 5/10/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Biogen Inc. stock logo
BIIB
Biogen
$9.66B3.36$18.88 per share11.80$102.14 per share2.18
Netflix, Inc. stock logo
NFLX
Netflix
$34.93B7.55$48.73 per share12.56$47.57 per share12.87
NIKE, Inc. stock logo
NKE
NIKE
$51.58B2.73$3.92 per share23.81$9.14 per share10.22

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Biogen Inc. stock logo
BIIB
Biogen
$1.16B$8.0127.8112.692.2112.07%14.83%8.19%7/23/2024 (Estimated)
Netflix, Inc. stock logo
NFLX
Netflix
$5.41B$14.4142.4827.601.4018.42%29.62%13.01%7/17/2024 (Estimated)
NIKE, Inc. stock logo
NKE
NIKE
$5.07B$3.4027.4723.641.7810.14%39.41%14.92%7/4/2024 (Estimated)

Latest BIIB, NKE, and NFLX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/24/2024Q1 2024
Biogen Inc. stock logo
BIIB
Biogen
$3.45$3.67+$0.22$4.64$2.31 billion$2.29 billion      
4/18/2024Q1 24
Netflix, Inc. stock logo
NFLX
Netflix
$4.51$5.28+$0.77$5.28$9.28 billion$9.37 billion    
3/21/2024Q3 2024
NIKE, Inc. stock logo
NKE
NIKE
$0.69$0.98+$0.29$1.19$12.28 billion$12.43 billion    
2/13/2024Q4 23
Biogen Inc. stock logo
BIIB
Biogen
$3.18$2.95-$0.23$4.19$2.47 billion$2.39 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Biogen Inc. stock logo
BIIB
Biogen
N/AN/AN/AN/AN/A
Netflix, Inc. stock logo
NFLX
Netflix
N/AN/AN/AN/AN/A
NIKE, Inc. stock logo
NKE
NIKE
$1.481.58%+11.23%43.53%21 Years

Latest BIIB, NKE, and NFLX Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/2/2024
NIKE, Inc. stock logo
NKE
NIKE
quarterly$0.371.6%6/3/20246/3/20247/1/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Biogen Inc. stock logo
BIIB
Biogen
0.41
2.10
1.32
Netflix, Inc. stock logo
NFLX
Netflix
0.62
1.07
1.07
NIKE, Inc. stock logo
NKE
NIKE
0.63
2.74
1.89

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Biogen Inc. stock logo
BIIB
Biogen
87.93%
Netflix, Inc. stock logo
NFLX
Netflix
80.93%
NIKE, Inc. stock logo
NKE
NIKE
64.25%

Insider Ownership

CompanyInsider Ownership
Biogen Inc. stock logo
BIIB
Biogen
0.60%
Netflix, Inc. stock logo
NFLX
Netflix
1.76%
NIKE, Inc. stock logo
NKE
NIKE
0.50%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Biogen Inc. stock logo
BIIB
Biogen
7,570145.60 million144.72 millionOptionable
Netflix, Inc. stock logo
NFLX
Netflix
13,000430.96 million423.38 millionOptionable
NIKE, Inc. stock logo
NKE
NIKE
83,7001.51 billion1.50 billionOptionable

BIIB, NKE, and NFLX Headlines

SourceHeadline
Monique S. Matheson Sells 45,000 Shares of NIKE, Inc. (NYSE:NKE) StockMonique S. Matheson Sells 45,000 Shares of NIKE, Inc. (NYSE:NKE) Stock
americanbankingnews.com - May 10 at 4:26 AM
NIKE (NYSE:NKE) Trading Down 0.2% Following Insider SellingNIKE (NYSE:NKE) Trading Down 0.2% Following Insider Selling
americanbankingnews.com - May 10 at 2:06 AM
How to buy Victor Wembanyamas new Nike GT Hustle 2How to buy Victor Wembanyama's new Nike GT Hustle 2
expressnews.com - May 9 at 9:05 PM
Zion Williamson’s Infamous Blown-Out Nike Sneaker From Duke Is Going Up for AuctionZion Williamson’s Infamous Blown-Out Nike Sneaker From Duke Is Going Up for Auction
sports.yahoo.com - May 9 at 4:05 PM
Dicks, NIKE to Host "Its Her Shot" TourDick's, NIKE to Host "It's Her Shot" Tour
msn.com - May 9 at 4:05 PM
NIKE, Inc. (NYSE:NKE) Shares Bought by National Pension ServiceNIKE, Inc. (NYSE:NKE) Shares Bought by National Pension Service
marketbeat.com - May 9 at 1:05 PM
NIKE (NYSE:NKE) Trading Down 0.2% on Insider SellingNIKE (NYSE:NKE) Trading Down 0.2% on Insider Selling
marketbeat.com - May 9 at 12:10 PM
7 photos inside the state-of-the-art new Nike: Rise shop at Trinity Leeds7 photos inside the state-of-the-art new Nike: Rise shop at Trinity Leeds
leeds-live.co.uk - May 9 at 11:04 AM
Nike Layoffs Announcement to Affect 740 Employees by June 28Nike Layoffs Announcement to Affect 740 Employees by June 28
thehrdigest.com - May 9 at 11:04 AM
DICKS Sporting Goods and Nike Announce Fourth Annual Its Her Shot TourDICK'S Sporting Goods and Nike Announce Fourth Annual It's Her Shot Tour
prnewswire.com - May 9 at 9:07 AM
Insider Selling: NIKE, Inc. (NYSE:NKE) EVP Sells 45,000 Shares of StockInsider Selling: NIKE, Inc. (NYSE:NKE) EVP Sells 45,000 Shares of Stock
insidertrades.com - May 9 at 8:48 AM
Nike Finally Re-Released Forrest Gump’s Iconic Cortez SneakersNike Finally Re-Released Forrest Gump’s Iconic Cortez Sneakers
msn.com - May 9 at 12:57 AM
Why Angel Reese Says She Chose A Multi-Year Endorsement Deal With Reebok Instead Of ‘Easily’ Signing With NikeWhy Angel Reese Says She Chose A Multi-Year Endorsement Deal With Reebok Instead Of ‘Easily’ Signing With Nike
sports.yahoo.com - May 8 at 7:57 PM
Tom Brady Rejects Lucrative $1B Nike Project, Opposing Woke Brands?Tom Brady Rejects Lucrative $1B Nike Project, Opposing 'Woke' Brands?
msn.com - May 8 at 7:57 PM
Longtime Nike designer behind iconic Air Max shoes leaves companyLongtime Nike designer behind iconic Air Max shoes leaves company
bizjournals.com - May 8 at 7:57 PM
NIKE, Inc. (NYSE:NKE) EVP Sells $4,237,200.00 in StockNIKE, Inc. (NYSE:NKE) EVP Sells $4,237,200.00 in Stock
marketbeat.com - May 8 at 6:54 PM
NIKE (NYSE:NKE) Trading Down 0.5%NIKE (NYSE:NKE) Trading Down 0.5%
marketbeat.com - May 8 at 5:53 PM
Charles Schwab Investment Management Inc. Cuts Stock Position in NIKE, Inc. (NYSE:NKE)Charles Schwab Investment Management Inc. Cuts Stock Position in NIKE, Inc. (NYSE:NKE)
marketbeat.com - May 8 at 1:32 PM
Nike announces opening date for exciting new Trinity Leeds shopNike announces opening date for exciting new Trinity Leeds shop
msn.com - May 8 at 7:32 AM
Should You Investigate NIKE, Inc. (NYSE:NKE) At US$93.78?Should You Investigate NIKE, Inc. (NYSE:NKE) At US$93.78?
finance.yahoo.com - May 8 at 7:32 AM
NIKE (NYSE:NKE) Trading Up 0.9%NIKE (NYSE:NKE) Trading Up 0.9%
marketbeat.com - May 7 at 4:37 PM
MLB, Nike announce change in uniforms for 2025MLB, Nike announce change in uniforms for 2025
malaysiasun.com - May 7 at 4:27 PM
Tim Cook sports Nike sneakers custom made for the iPad launchTim Cook sports Nike sneakers custom made for the iPad launch
appleinsider.com - May 7 at 4:27 PM
Nikes Bestselling Golf Shirt Thats Perfect for Early Morning Rounds Is Now Under $50 and Selling Out FastNike's Bestselling Golf Shirt That's 'Perfect for Early Morning Rounds' Is Now Under $50 and Selling Out Fast
mensjournal.com - May 7 at 4:27 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Biogen logo

Biogen

NASDAQ:BIIB
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally. The company provides TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; ADUHELM to treat Alzheimer's disease; FUMADERM to treat plaque psoriasis; BENEPALI, an etanercept biosimilar referencing ENBREL; IMRALDI, an adalimumab biosimilar referencing HUMIRA; FLIXABI, an infliximab biosimilar referencing REMICADE; and BYOOVIZ, a ranibizumab biosimilar referencing LUCENTIS. It offers RITUXAN for treating non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, two forms of ANCA-associated vasculitis, and pemphigus vulgaris; RITUXAN HYCELA for non-Hodgkin's lymphoma and CLL; GAZYVA to treat CLL and follicular lymphoma; OCREVUS for relapsing MS and primary progressive MS; LUNSUMIO to treat relapsed or refractory follicular lymphoma; glofitamab for non-Hodgkin's lymphoma; and other anti-CD20 therapies. In addition, the company is developing various products for the treatment of MS, Alzheimer's disease and dementia, neuromuscular disorders, Parkinson's disease and movement disorders, neuropsychiatry, genetic neurodevelopmental disorders, and biosimilars, which are under various stages of development. It has collaboration and license agreements with Acorda Therapeutics, Inc.; Alkermes Pharma Ireland Limited; Denali Therapeutics Inc.; Eisai Co., Ltd.; Genentech, Inc.; Neurimmune SubOne AG; Ionis Pharmaceuticals, Inc.; Samsung Bioepis Co., Ltd.; Sangamo Therapeutics, Inc.; and Sage Therapeutics, Inc. The company was founded in 1978 and is headquartered in Cambridge, Massachusetts.
Netflix logo

Netflix

NASDAQ:NFLX
Netflix, Inc. provides entertainment services. It offers TV series, documentaries, feature films, and games across various genres and languages. The company also provides members the ability to receive streaming content through a host of internet-connected devices, including TVs, digital video players, TV set-top boxes, and mobile devices. It has operations in approximately 190 countries. The company was incorporated in 1997 and is headquartered in Los Gatos, California.
NIKE logo

NIKE

NYSE:NKE
NIKE, Inc., together with its subsidiaries, designs, develops, markets, and sells athletic footwear, apparel, equipment, accessories, and services worldwide. The company provides athletic and casual footwear, apparel, and accessories under the Jumpman trademark; and casual sneakers, apparel, and accessories under the Converse, Chuck Taylor, All Star, One Star, Star Chevron, and Jack Purcell trademarks. It also sells a line of performance equipment and accessories comprising bags, sport balls, socks, eyewear, timepieces, digital devices, bats, gloves, protective equipment, and other equipment for sports activities under the NIKE brand; and various plastic products to other manufacturers. In addition, the company markets apparel with licensed college and professional team, and league logos, as well as sells sports apparel; and licenses unaffiliated parties to manufacture and sell apparel, digital devices, and applications and other equipment for sports activities under NIKE-owned trademarks. It sells its products to footwear stores; sporting goods stores; athletic specialty stores; department stores; skate, tennis, and golf shops; and other retail accounts through NIKE-owned retail stores, digital platforms, independent distributors, licensees, and sales representatives. NIKE, Inc. was founded in 1964 and is headquartered in Beaverton, Oregon.